Atossa revenue plummets in Q2

Atossa Genetics (ATOS -1.7%) Q2 results: Revenues: $10.0K (-97.0%); Operating Expenses: $3.2M (+18.5%); Net Loss: ($3.2M) (-23.4%); Loss Per Share: ($0.23) (-35.3%); Quick Assets: $14.3M (+125.5%).

No financial guidance given.

Comments (2)
  • pat walsh
    , contributor
    Comments (341) | Send Message
    12 Aug 2014, 05:22 PM Reply Like
  • rondressler0
    , contributor
    Comments (15) | Send Message
    Plummets? FDA having shut off sales, did you expect an increase in revenue??
    12 Aug 2014, 07:52 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs